Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Selecting haematological malignancy patients for intravenous immunoglobulin

Simple item page
dc.contributor.authorPaxton, Luis
dc.contributor.authorHawkins, Carolyn
dc.contributor.authorCrispin, Philip
dc.date.accessioned2023-02-10T03:51:03Z
dc.date.issued2016
dc.date.updated2021-12-02T05:02:58Z
dc.description.abstractPrior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high-risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1444-0903en_AU
dc.identifier.urihttp://hdl.handle.net/1885/285139
dc.language.isoen_AUen_AU
dc.publisherWileyen_AU
dc.rights© 2016 Royal Australasian College of Physiciansen_AU
dc.sourceInternal Medicine Journalen_AU
dc.subjectintravenous immunoglobulinen_AU
dc.subjecthaematologicalmalignancyen_AU
dc.subjectinfectionen_AU
dc.titleSelecting haematological malignancy patients for intravenous immunoglobulinen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue10en_AU
local.bibliographicCitation.lastpage1218en_AU
local.bibliographicCitation.startpage1216en_AU
local.contributor.affiliationPaxton, Luis , College of Health and Medicine, ANUen_AU
local.contributor.affiliationHawkins, Carolyn, College of Health and Medicine, ANUen_AU
local.contributor.affiliationCrispin, Philip, College of Health and Medicine, ANUen_AU
local.contributor.authoruidPaxton, Luis , u5381785en_AU
local.contributor.authoruidHawkins, Carolyn, u2572651en_AU
local.contributor.authoruidCrispin, Philip, u5115694en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor320102 - Haematologyen_AU
local.identifier.absfor320199 - Cardiovascular medicine and haematology not elsewhere classifieden_AU
local.identifier.ariespublicationa383154xPUB4517en_AU
local.identifier.citationvolume46en_AU
local.identifier.doi10.1111/imj.13205en_AU
local.identifier.scopusID2-s2.0-84992029030
local.identifier.thomsonID000387335400014
local.publisher.urlhttps://www.wiley.com/en-gben_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Internal Medicine Journal - 2016 - Paxton - Selecting haematological malignancy patients for intravenous immunoglobulin.pdf
Size:
50.36 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS